J. Edward Moreno
@edwrdmoreno
Followers
2K
Following
27K
Media
55
Statuses
3K
Reporter @Sherwood_News. Say hi: [email protected], jedwardmoreno.04 on Signal https://t.co/BeGhwWYT4y
NYC
Joined November 2013
Having a unique product is better for margins and customer retention. But some of the combinations they advertise make doctors I spoke to uneasy. https://t.co/9ZgcC8RV2T
sherwood.news
Combination pills, like those that treat ED and hair loss at the same time, help companies like Hims & Hers and Ro with customer retention. But...
2
0
3
$Hims just announced its adding oral testosterone treatments, starting with compounded enclomiphene. Injectable TRT is coming next year, the company said.
2
0
0
I talked to BlueChew's CEO about how he built the company, where he sees it going next, and what it was like to be on the trading floor at Citi during the financial crisis.
sherwood.news
In an industry dominated by venture cash and fads, BlueChew’s CEO says independence and focus help him succeed....
0
0
1
I sat down with $LYFT CEO David Risher to talk about how the company turned profitable and how its thinking about AVs and international expansion.
sherwood.news
Lyft wants to shed its “second-place, domestic-only, only a business-to-consumer company” reputation....
0
1
1
I spoke to Ro CEO Zachariah Reitano about how GLP-1s paved the way for direct-to-consumer pharma sales, which more and more drugmakers are leaning in to.
sherwood.news
Normally, if your insurer doesn’t cover a medication, you would buy it directly from your pharmacy, which bought it from a wholesaler, which...
0
0
5
Following #EliLilly’s #Q2Earnings beat, Client PM Brian Mulberry spoke with @edwrdmoreno of @sherwood_news and shared that a "blowout in revenue" and earnings per share is great, but “we want to know where growth is headed.” Read more: https://t.co/VdeXZKqTcq
1
1
1
This marks the first quarter that Lilly’s GLP-1s have outsold Novo’s. $LLY $NVO
3
5
11
A spokesperson for the BLS confirmed McEntarfer was terminated on Friday and said Deputy Commissioner William Wiatrowski will serve as acting commissioner.
sherwood.news
The weak jobs numbers come as the administration has sought to fend off criticisms of how its shifting trade policies have impacted the economy....
0
0
3
Scooplet: $LLY told me it has terminated its partnership with Noom after the telehealth platform continued to promote “microdosed” GLP-1s.
sherwood.news
The end of the partnership marks the latest schism between drugmakers and telehealth providers....
0
0
12
$CMG reported a second consecutive quarter of SSS decline
1
0
0
$LLY appears to be fattening its stockpiles of GLP-1s as the threat of tariffs on pharmaceuticals looms.
1
4
8
$GRND thinks there’s room for yet another ED telehealth brand. They might be right.
sherwood.news
From stoic Senator Bob Dole to racy ads targeting men on a gay dating app, erectile dysfunction marketing has changed wildly over the past three...
0
1
2
“It definitely came as a surprise”: How the $NVO / $HIMS partnership flopped in just two months https://t.co/EAYbW5pbd5
sherwood.news
Meanwhile, customers are wondering, “Are they going to refund us or what?”...
1
0
0
$Hims is down by ~30% after $Nvo called off their partnership with the telehealth platform
1
0
0
I wrote about how telehealth companies like $HIMS, Ro and BlueChew are increasingly marketing pills that cram multiple drugs into the same pill, add supplements, and often make it taste like candy. (link below)
1
2
5
(This reporter is not responsible for advertisements you get served after reading this article...)
0
0
0